DK1294677T3 - Benzophenoner og sulfoner som inhibitorer af glycinoptagelse - Google Patents
Benzophenoner og sulfoner som inhibitorer af glycinoptagelseInfo
- Publication number
- DK1294677T3 DK1294677T3 DK01940919T DK01940919T DK1294677T3 DK 1294677 T3 DK1294677 T3 DK 1294677T3 DK 01940919 T DK01940919 T DK 01940919T DK 01940919 T DK01940919 T DK 01940919T DK 1294677 T3 DK1294677 T3 DK 1294677T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzophenones
- sulfones
- inhibitors
- glycine uptake
- uptake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21569200P | 2000-06-30 | 2000-06-30 | |
PCT/IB2001/001139 WO2002000602A1 (en) | 2000-06-30 | 2001-06-22 | Benzophenones and sulfones as inhibitors of glycine uptake |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1294677T3 true DK1294677T3 (da) | 2005-02-07 |
Family
ID=22803976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01940919T DK1294677T3 (da) | 2000-06-30 | 2001-06-22 | Benzophenoner og sulfoner som inhibitorer af glycinoptagelse |
Country Status (17)
Country | Link |
---|---|
US (1) | US6506780B2 (da) |
EP (1) | EP1294677B1 (da) |
JP (1) | JP3801561B2 (da) |
AP (1) | AP2001002203A0 (da) |
AR (1) | AR033828A1 (da) |
AT (1) | ATE281427T1 (da) |
AU (1) | AU2001274407A1 (da) |
DE (1) | DE60106914T2 (da) |
DK (1) | DK1294677T3 (da) |
DO (1) | DOP2001000189A (da) |
ES (1) | ES2230326T3 (da) |
PA (1) | PA8519901A1 (da) |
PE (1) | PE20020121A1 (da) |
PT (1) | PT1294677E (da) |
TN (1) | TNSN01098A1 (da) |
UY (1) | UY26802A1 (da) |
WO (1) | WO2002000602A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566550B2 (en) | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
IL154318A (en) * | 2003-02-06 | 2010-05-31 | Sarah Herzog Memorial Hospital | Pharmaceutical compositions for the treatment of movement disorders |
WO2004096761A1 (en) * | 2003-04-30 | 2004-11-11 | H. Lundbeck A/S | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
WO2005018676A1 (en) * | 2003-08-21 | 2005-03-03 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
WO2005100301A1 (en) * | 2004-03-31 | 2005-10-27 | Eli Lilly And Company | 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors |
AU2006207650B2 (en) * | 2005-01-18 | 2011-01-27 | F. Hoffmann-La Roche Ag | 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders |
MX2007009342A (es) * | 2005-02-07 | 2007-09-21 | Hoffmann La Roche | Fenil-metanonas sustituidas por heterociclo como inhibidor del transportador 1 de glicina. |
EP2001831A2 (en) * | 2006-04-05 | 2008-12-17 | Glaxo Group Limited | Compounds which inhibit the glycine transporter and uses thereof |
PL2699543T3 (pl) * | 2011-04-19 | 2016-10-31 | Nowe modulatory mediowanego receptorem dopaminergicznym i nmda glutaminergicznego przekaźnictwa nerwowego zwojów korowych | |
WO2013128619A1 (ja) | 2012-03-01 | 2013-09-06 | トヨタ自動車株式会社 | 車体構造 |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191165B1 (en) * | 1996-05-31 | 2001-02-20 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
DK1014966T3 (da) * | 1996-05-31 | 2006-12-04 | Allelix Neuroscience Inc | Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser |
-
2001
- 2001-06-15 DO DO2001000189A patent/DOP2001000189A/es unknown
- 2001-06-18 PA PA20018519901A patent/PA8519901A1/es unknown
- 2001-06-22 JP JP2002505351A patent/JP3801561B2/ja not_active Expired - Fee Related
- 2001-06-22 PT PT01940919T patent/PT1294677E/pt unknown
- 2001-06-22 WO PCT/IB2001/001139 patent/WO2002000602A1/en active IP Right Grant
- 2001-06-22 DE DE60106914T patent/DE60106914T2/de not_active Expired - Fee Related
- 2001-06-22 AP APAP/P/2001/002203A patent/AP2001002203A0/en unknown
- 2001-06-22 EP EP01940919A patent/EP1294677B1/en not_active Expired - Lifetime
- 2001-06-22 AT AT01940919T patent/ATE281427T1/de not_active IP Right Cessation
- 2001-06-22 ES ES01940919T patent/ES2230326T3/es not_active Expired - Lifetime
- 2001-06-22 AU AU2001274407A patent/AU2001274407A1/en not_active Abandoned
- 2001-06-22 DK DK01940919T patent/DK1294677T3/da active
- 2001-06-26 PE PE2001000625A patent/PE20020121A1/es not_active Application Discontinuation
- 2001-06-27 UY UY26802A patent/UY26802A1/es unknown
- 2001-06-28 AR ARP010103089A patent/AR033828A1/es unknown
- 2001-06-29 TN TNTNSN01098A patent/TNSN01098A1/fr unknown
- 2001-07-02 US US09/897,261 patent/US6506780B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3801561B2 (ja) | 2006-07-26 |
EP1294677A1 (en) | 2003-03-26 |
DE60106914T2 (de) | 2005-12-08 |
PE20020121A1 (es) | 2002-02-16 |
DOP2001000189A (es) | 2002-03-30 |
ATE281427T1 (de) | 2004-11-15 |
DE60106914D1 (de) | 2004-12-09 |
TNSN01098A1 (fr) | 2005-11-10 |
US20020052401A1 (en) | 2002-05-02 |
AP2001002203A0 (en) | 2001-09-30 |
ES2230326T3 (es) | 2005-05-01 |
EP1294677B1 (en) | 2004-11-03 |
WO2002000602A1 (en) | 2002-01-03 |
PA8519901A1 (es) | 2003-06-30 |
US6506780B2 (en) | 2003-01-14 |
UY26802A1 (es) | 2002-01-31 |
JP2004501892A (ja) | 2004-01-22 |
PT1294677E (pt) | 2005-01-31 |
AR033828A1 (es) | 2004-01-07 |
AU2001274407A1 (en) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1307744T3 (da) | Analyseapparat | |
DK1202941T3 (da) | Gipssammensætninger og beslægtede fremgangsmåder | |
NO992492D0 (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
CY2012007I2 (el) | Πεπτιδομιμητικοι αναστολεις πρωτεασης | |
DK1578771T3 (da) | Remodellering og glycokonjugering af peptider | |
CY2004011I1 (el) | Aσυμμετρη συνθεση της πρεγαβαλινης | |
DE60114484D1 (de) | Verdichter | |
IL157348A0 (en) | Benzophenones as inhibitors of reverse transcriptase | |
DE60123168D1 (de) | MPEG-Dekoder | |
DK1325100T3 (da) | Sammensætninger og fremgangsmåder til rensning af kontaktlinser | |
DK1458447T3 (da) | Kombination af cytokrom-p450-beroende proteasinhibitorer | |
NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
DK1272488T3 (da) | Tri-aryl-substitueret ethan-PDE4-inhibitorer | |
DK1294677T3 (da) | Benzophenoner og sulfoner som inhibitorer af glycinoptagelse | |
NO20034995L (no) | Aromatiske sulfonhydroksymater og deres anvendelse som proteaseinhibitorer | |
NO20013853D0 (no) | Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer | |
NO20025786D0 (no) | Protaseinhibitorer | |
NO20030243D0 (no) | Nye forbindelser og deres anvendelse som glysintransportinhibitorer | |
PT1339695E (pt) | Inibidores da farnesiltransferase | |
NO20025005D0 (no) | Proteaseinhibitorer | |
NO20033921D0 (no) | Inhibitor av monoaminopptak | |
DE60123315D1 (de) | Analysegerät | |
AR028075A1 (es) | Inhibidores de la peptido-desformilasa | |
DE60132468D1 (de) | Alen-lanosterol zyklase inhibitoren | |
NO20032328D0 (no) | Proteaseinhibitorer |